Teva Kicks The Can Down The Road

Teva amended leverage covenants in certain of its credit agreements, but it does not improve the company's credit metrics. Headwinds in generics and Copaxone could send its debt deeper into junk territory. Teva is kicking the can down the road.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.